A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations

(2013) Priscilla K Brastianos et al.   NATURE GENETICS

Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO

(2013) V. E. Clark et al.   SCIENCE

Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro

(2012) C Pfister et al.   BRITISH JOURNAL OF CANCER

Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysis

(2012) Peter Horak et al.   JOURNAL OF NEURO-ONCOLOGY

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

(2012) Emil Lou et al.   JOURNAL OF NEURO-ONCOLOGY

Atypical and anaplastic meningiomas treated with bevacizumab

(2012) Lakshmi Nayak et al.   JOURNAL OF NEURO-ONCOLOGY

Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study

(2011) Tanya B. Dorff et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

(2011) David A. Reardon et al.   JOURNAL OF NEURO-ONCOLOGY

Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series

(2011) Marc C. Chamberlain et al.   JOURNAL OF NEURO-ONCOLOGY

Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma

(2011) Marc C. Chamberlain   JOURNAL OF NEURO-ONCOLOGY

Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma

(2011) D. R. Johnson et al.   NEURO-ONCOLOGY

Angiogenesis as a predictor of recurrence in meningiomas

(2010) Valeria Barresi   JOURNAL OF NEURO-ONCOLOGY

Aberrant signaling pathways in meningiomas

(2010) Brian T. Ragel et al.   JOURNAL OF NEURO-ONCOLOGY

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma

(2009) Andrew D. Norden et al.   JOURNAL OF NEURO-ONCOLOGY

Fibroblast growth factor receptor–3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase–Akt pathway

(2009) Mahlon D. Johnson et al.   JOURNAL OF NEUROSURGERY

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

(2009) Patrick Y. Wen et al.   NEURO-ONCOLOGY

Interferon-α for recurrent World Health Organization grade 1 intracranial meningiomas

(2008) Marc C. Chamberlain et al.   CANCER